Pricing Log in Create free account

BioVie Inc. (BIVI) vs Chemomab Therapeutics Ltd. Sponsored ADR (CMMB)

BioVie Inc. and Chemomab Therapeutics Ltd. Sponsored ADR are both Biotechnology companies. BioVie Inc. and Chemomab Therapeutics Ltd. Sponsored ADR are of similar size ($9.6M and $9.4M). Across the 9 metrics below, Chemomab Therapeutics Ltd. Sponsored ADR leads on 5 and BioVie Inc. on 4.

Valuation

Metric BIVI CMMB Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 0.85 1.17 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield (262.50%) (63.03%) (33.15%)
Free cash flow yield (218.80%) (358.23%) (25.50%)

Profitability

Metric BIVI CMMB Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (151.06%) (82.17%) (56.36%)
Return on assets (123.51%) (70.70%) (48.04%)
Return on invested capital (1,095.01%) (247.40%) 0.00%

Growth

Metric BIVI CMMB Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 74.83% 58.14% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BIVI CMMB Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.59 6.41 4.72
Net debt to EBITDA 0.40 1.09 0.96

Dividend

Metric BIVI CMMB Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BIVI CMMB Biotechnology median
Market cap 9.64m 9.35m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack